Published in AIDS on May 28, 1999
Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet (2010) 6.02
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health (2008) 5.32
Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis (2008) 4.18
Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis (2007) 3.02
Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis (2009) 2.89
Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis (2011) 2.88
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med (2009) 2.48
Predictors of disease progression in HIV infection: a review. AIDS Res Ther (2007) 2.05
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther (2008) 1.83
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (2013) 1.72
Anemia and growth failure among HIV-infected children in India: a retrospective analysis. BMC Pediatr (2009) 1.44
Profile of hematological abnormalities of Indian HIV infected individuals. BMC Blood Disord (2009) 1.39
Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART. Afr Health Sci (2011) 1.37
Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania. BMC Infect Dis (2011) 1.29
Blood haemoglobin measurement as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci (2009) 1.18
Association between use of HMG CoA reductase inhibitors and mortality in HIV-infected patients. PLoS One (2011) 1.12
Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis. BMC Public Health (2009) 1.10
The prevalence and etiology of anemia among HIV-infected children in India. Eur J Pediatr (2011) 1.06
Iron deficiency anemia: focus on infectious diseases in lesser developed countries. Anemia (2011) 1.06
Anemia in human immunodeficiency virus-infected and uninfected women in Rwanda. Am J Trop Med Hyg (2011) 1.05
Factors associated with anaemia in HIV-infected individuals in southern India. Int J STD AIDS (2009) 1.05
Nutritional indicators of adverse pregnancy outcomes and mother-to-child transmission of HIV among HIV-infected women. Am J Clin Nutr (2008) 1.04
Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study. PLoS One (2013) 1.01
Predictive value of anemia for tuberculosis in HIV-infected patients in Sub-Saharan Africa: an indication for routine microbiological investigation using new rapid assays. J Acquir Immune Defic Syndr (2014) 0.99
Anaemia in HIV-infected children: severity, types and effect on response to HAART. BMC Pediatr (2012) 0.97
Anaemia in acute HIV-1 subtype C infection. PLoS One (2008) 0.96
Resolution of anaemia in a cohort of HIV-infected patients with a high prevalence and incidence of tuberculosis receiving antiretroviral therapy in South Africa. BMC Infect Dis (2014) 0.96
Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions. Virology (2009) 0.95
Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study. PLoS One (2012) 0.95
Physiological correlates of HIV-related fatigue. Clin Nurs Res (2008) 0.93
Gender-related differences in outcomes and attrition on antiretroviral treatment among an HIV-infected patient cohort in Zimbabwe: 2007-2010. Int J Infect Dis (2014) 0.93
Anemia among HIV-Infected Patients Initiating Antiretroviral Therapy in South Africa: Improvement in Hemoglobin regardless of Degree of Immunosuppression and the Initiating ART Regimen. J Trop Med (2013) 0.92
Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda. BMC Infect Dis (2014) 0.91
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages. World J Virol (2013) 0.88
Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia. BMC Hematol (2013) 0.88
Paving the path to HIV neurotherapy: Predicting SIV CNS disease. Eur J Pharmacol (2015) 0.88
Erythropoiesis in HIV-infected and uninfected Malawian children with severe anemia. AIDS (2010) 0.87
Predictors of Mortality among Tuberculosis/HIV-Coinfected Persons in Southwest Ethiopia: A Case-Control Study. J Int Assoc Provid AIDS Care (2013) 0.87
Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease. AIDS (2014) 0.87
The prevalence of malaria among HIV seropositive individuals and the impact of the co- infection on their hemoglobin levels. Ann Clin Microbiol Antimicrob (2015) 0.86
Predictors and consequences of anaemia among antiretroviral-naïve HIV-infected and HIV-uninfected children in Tanzania. Public Health Nutr (2009) 0.85
Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality. Am J Ophthalmol (2011) 0.84
Severe anaemia is not associated with HIV-1 env gene characteristics in Malawian children. BMC Infect Dis (2008) 0.83
Incidence and risk factors for tuberculosis in people living with HIV: cohort from HIV referral health centers in Recife, Brazil. PLoS One (2013) 0.83
Effects of nutrition counseling and monitoring on the weight and hemoglobin of patients receiving antiretroviral therapy in Ebonyi State, Southeast Nigeria. HIV AIDS (Auckl) (2014) 0.83
Haemoglobin and anaemia in the SMART study. Antivir Ther (2011) 0.82
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon. Infect Dis Poverty (2014) 0.82
Treatment outcomes among HIV-1 and HIV-2 infected children initiating antiretroviral therapy in a concentrated low prevalence setting in West Africa. BMC Pediatr (2012) 0.82
AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS). BMC Infect Dis (2004) 0.82
Anemia in a cohort of HIV-infected Hispanics: prevalence, associated factors and impact on one-year mortality. BMC Res Notes (2014) 0.82
Anaemia and Iron Homeostasis in a Cohort of HIV-Infected Patients: A Cross-Sectional Study in Ghana. AIDS Res Treat (2016) 0.81
Hemoglobin may contribute to sex differences in mortality among HIV-infected persons in care. PLoS One (2012) 0.81
Clinical Evaluation of the BD FACSPresto™ Near-Patient CD4 Counter in Kenya. PLoS One (2016) 0.81
HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe. AIDS Res Hum Retroviruses (2014) 0.81
Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study. AIDS Res Ther (2015) 0.81
Assessing the impact of feline immunodeficiency virus and bovine tuberculosis co-infection in African lions. Proc Biol Sci (2012) 0.80
Depression Correlates with Increased Plasma Levels of Inflammatory Cytokines and a Dysregulated Oxidant/Antioxidant Balance in HIV-1-Infected Subjects Undergoing Antiretroviral Therapy. J Clin Cell Immunol (2014) 0.79
Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens. J Int Assoc Provid AIDS Care (2014) 0.78
Incidence and predictors of recovery from anaemia within an HIV-infected South African Cohort, 2004-2010. Pan Afr Med J (2014) 0.78
Prevalence and correlates of anemia among HIV infected patients on highly active anti-retroviral therapy at Zewditu Memorial Hospital, Ethiopia. BMC Hematol (2015) 0.78
A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease. Blood (2011) 0.78
Chest radiographic pulmonary changes reflecting extrapulmonary involvement in paediatric HIV disease. Pediatr Radiol (2009) 0.78
The impact of impaired kidney function and HIV infection on the risk of anemia. AIDS Res Hum Retroviruses (2012) 0.78
Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based study. Pan Afr Med J (2016) 0.77
Elevated Hepcidin Is Part of a Complex Relation That Links Mortality with Iron Homeostasis and Anemia in Men and Women with HIV Infection. J Nutr (2015) 0.77
Prevalence and associated risk factors of anemia among HIV infected children attending Gondar university hospital, Northwest Ethiopia: a cross sectional study. BMC Hematol (2015) 0.76
Post-natal anaemia and iron deficiency in HIV-infected women and the health and survival of their children. Matern Child Nutr (2012) 0.76
Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: results from the TREAT Asia HIV observational database. J Int Assoc Provid AIDS Care (2013) 0.76
Practical Management of HIV-Associated Anemia in Resource-Limited Settings: Prospective Observational Evaluation of a New Mozambican Guideline. AIDS Res Hum Retroviruses (2015) 0.75
HIV-Care Outcome in Saudi Arabia; a Longitudinal Cohort. J AIDS Clin Res (2014) 0.75
Hyponatremia is a marker of disease severity in HIV-infected patients: a retrospective cohort study. BMC Infect Dis (2017) 0.75
Profile of blood cell abnormalities among antiretroviral therapy naïve HIV patients attending the Yaounde University Teaching Hospital, Cameroon. BMC Hematol (2014) 0.75
Approach to Anemia in Hospitalized Patients with Infectious Diseases; Is it Appropriate? Iran J Pharm Res (2015) 0.75
Association of hematological profile of human immunodeficiency virus-positive patients with clinicoimmunologic stages of the disease. J Lab Physicians (2013) 0.75
[Study of anemia in HIV positive children naive to antiretroviral treatment in Lubumbashi, Democratic Republic of Congo]. Pan Afr Med J (2014) 0.75
Trends in the Treatment of Anemia Using Recombinant Human Erythropoietin in Patients with HIV Infection. Open AIDS J (2011) 0.75
High Incidence of Tuberculosis in the Absence of Isoniazid and Cotrimoxazole Preventive Therapy in Children Living with HIV in Northern Ethiopia: A Retrospective Follow-Up Study. PLoS One (2016) 0.75
Total Lymphocyte Count and Haemoglobin Concentration Combined as a Surrogate Marker for Initiating Highly Active Antiretroviral Therapy in a Resource-limited Setting as against CD4 Cell Count. West Indian Med J (2014) 0.75
Profile of HIV-Infected Hispanics with Pancytopenia. Int J Environ Res Public Health (2015) 0.75
Can Metabolic Factors be used Prognostically for Short-Term Mortality in HIV-Infected Patients? Ann Med Health Sci Res (2012) 0.75
Determinants of Anemia Among Human Immunodeficiency Virus-Positive Adults at Care and Treatment Clinics in Dar es Salaam, Tanzania. Am J Trop Med Hyg (2015) 0.75
G6PD Deficiency in an HIV Clinic Setting in the Dominican Republic. Am J Trop Med Hyg (2015) 0.75
Malaria infection and anaemia in HIV-infected children in Mutengene, Southwest Cameroon: a cross sectional study. BMC Infect Dis (2016) 0.75
Anaemia in pregnancy is associated with advanced HIV disease. PLoS One (2014) 0.75
Prevalence of anemia in renal insufficiency among HIV infected patients initiating ART at a hospital in Northeast Ethiopia. BMC Hematol (2017) 0.75
Predictors of Persistent Anaemia in the First Year of Antiretroviral Therapy: A Retrospective Cohort Study from Goma, the Democratic Republic of Congo. PLoS One (2015) 0.75
The role of red blood cells in enhancing or preventing HIV infection and other diseases. Biomed Res Int (2013) 0.75
Food Security in Households of People Living With Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: A Cross-sectional Study in a Subdivision of Darjeeling District, West Bengal. J Prev Med Public Health (2016) 0.75
Cytopenias among ART-naive patients with advanced HIV disease on enrolment to care and treatment services at a tertiary hospital in Tanzania: A cross-sectional study. Malawi Med J (2017) 0.75
A Rare Cause of Anaemia in HIV/AIDS. J Clin Diagn Res (2017) 0.75
Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 38.85
CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med (2006) 22.76
Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet (2003) 7.94
Abnormal splicing of the leptin receptor in diabetic mice. Nature (1996) 7.71
Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med (2001) 7.71
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53
Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis (1999) 5.59
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet (2000) 5.49
Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38
Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee. J Infect Dis (1999) 4.18
Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis (1997) 3.86
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial. Ann Intern Med (2008) 3.68
Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci U S A (1995) 3.33
Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med (1989) 3.32
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies. Lancet (2003) 3.23
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA (2001) 2.95
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS (2002) 2.90
Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. Lancet (1999) 2.80
HTLV-III/LAV viral antigens in lymph nodes of homosexual men with persistent generalized lymphadenopathy and AIDS. Am J Pathol (1986) 2.77
Epidemiologic and clinical aspects of the Ebola virus epidemic in Mosango, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 2.70
Late presentation of HIV infection: a consensus definition. HIV Med (2011) 2.67
High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology (1993) 2.65
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. JAMA (1994) 2.56
Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine. Antimicrob Agents Chemother (1985) 2.55
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study. Arch Intern Med (2000) 2.49
Rolling out antiretrovirals in Africa: there are still challenges ahead. Clin Infect Dis (2005) 2.43
An objective case definition of lipodystrophy in HIV-infected adults: a case-control study. Lancet (2003) 2.43
Improved diagnosis of Pneumocystis carinii infection by polymerase chain reaction on induced sputum and blood. Lancet (1992) 2.40
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study. HIV Med (2006) 2.38
Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood (2001) 2.37
Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study. HIV Med (2003) 2.30
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J Infect Dis (2004) 2.26
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin. Antimicrob Agents Chemother (1985) 2.25
Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis (2001) 2.19
HIV testing in developing countries. Lancet (1997) 2.19
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor. AIDS (2000) 2.14
AIDS across Europe, 1994-98: the EuroSIDA study. Lancet (2000) 2.13
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11
Insurance and HIV antibody testing. Lancet (1992) 2.08
Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis (1999) 2.06
Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet (1985) 2.01
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet (2001) 2.01
Soluble tumor necrosis factor receptors correlate with parasitemia and disease severity in human malaria. J Infect Dis (1992) 1.98
Cardio- and cerebrovascular events in HIV-infected persons. AIDS (2004) 1.98
Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group. Int J Epidemiol (1997) 1.97
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group. Lancet (1999) 1.95
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era. Clin Infect Dis (2013) 1.91
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer (2010) 1.86
Organization of patient care during the Ebola hemorrhagic fever epidemic in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis (1999) 1.86
Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med (1996) 1.82
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med (2012) 1.76
Recurrence of blackwater fever: triggering of relapses by different antimalarials. Trop Med Int Health (1998) 1.75
Ebola outbreak in Kikwit, Democratic Republic of the Congo: discovery and control measures. J Infect Dis (1999) 1.73
Loss to follow-up in an international, multicentre observational study. HIV Med (2008) 1.70
Mandatory prenatal screening for the human immunodeficiency virus: the experience in south-eastern France of a national policy, 1992-1994. Br J Obstet Gynaecol (1998) 1.68
Cloning of the Escherichia coli K-12 hemB gene. J Bacteriol (1988) 1.67
Antenatal serum screening for genital herpes: a study of knowledge and attitudes of women at a central London hospital. Br J Obstet Gynaecol (1997) 1.62
Improvement of the patient flow in a large urban clinic with high HIV seroprevalence in Kampala, Uganda. Int J STD AIDS (2009) 1.59
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD. Am J Respir Crit Care Med (2000) 1.55
Spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complexes. Prog Allergy (1986) 1.53
Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS. AIDS in Europe Study Group. Clin Infect Dis (1995) 1.51
The case for indicator condition-guided HIV screening. HIV Med (2013) 1.48
Antenatal testing for HIV: to opt in or opt out, that is the question. Br J Obstet Gynaecol (1996) 1.46
Survey among survivors of the 1995 Ebola epidemic in Kikwit, Democratic Republic of Congo: their feelings and experiences. Trop Med Int Health (1998) 1.44
Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. J Infect Dis (2001) 1.44
Severe bacterial non-aids infections in HIV-positive persons: incidence rates and risk factors. J Infect (2013) 1.43
Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*). HIV Med (2011) 1.43
Structure-activity studies of glucagon-like peptide-1. J Biol Chem (1994) 1.42
Ebola hemorrhagic fever and pregnancy. J Infect Dis (1999) 1.41
Failure to maintain patient access to GUM clinics. Sex Transm Infect (2004) 1.41
Survival differences in European patients with AIDS, 1979-89. The AIDS in Europe Study Group. BMJ (1994) 1.41